Put differently: if you tried to anchor the dose on BPC-157 or TB-500 instead (which are usually run at higher standalone amounts), you would have to inject a much larger volume and would flood GHK-Cu far past its useful range
Additionally, tirzepatide, a novel GLP-1/GIP co-agonist, has received approval for managing type 2 diabetes mellitus and is showing promising tirzepatide weight loss results, signifying a potential paradigm shift in weight loss strategies [1]
Either way its been easier to loose the unnecessary pounds
Moreover, participants in clinical trials experienced an impressive increase in GLP-1 levels by over 200% on average
Found offers brand-name GLP-1s (like Wegovy, Zepbound, and Ozempic), oral options like Rybelsus, and compounded semaglutide, though compounded versions arent FDA-approved and may not be available in your state
Ashwood, P